AE

Loading...

Syndromic solutions to aid therapeutic decision making for patients with respiratory infection

213 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 12, 2019

In the clinical lab, acute conditions like respiratory disease require immediate intervention. Minutes count. Correct identification of the causative pathogen is key to selecting the right treatment, but many pathogens cause similar symptoms. Multiplex syndromic testing with the QIAstat-Dx, rapidly and simultaneously surveys a large number of pathogens, helping to eliminate the guesswork. These more accurate, comprehensive and actionable results allow your lab to provide clinicians with the information they need to confidently diagnose and guide therapy selection, improving patient care.

Treating respiratory disease without a proper diagnosis can result in unnecessary prescribing of antibiotics, one of the driving forces for multidrug resistance in bacteria. Dr. Utsav Pandey from Children’s Hospital LA discusses the importance of syndromic testing to obtain an accurate diagnosis and treatment.

Learn more about syndromic testing with the QIAstat-Dx: https://qiastat-dx.com/

Subscribe to the QIAGEN YouTube channel: https://www.youtube.com/QIAGEN

Follow us on:
Twitter: https://twitter.com/QIAGEN
Facebook: https://www.facebook.com/QIAGEN/
Linkedin: https://www.linkedin.com/company/8276/
Instagram: https://www.instagram.com/qiagen/

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...